In Vitro Evaluation of the Effects of Eurycoma longifolia Extract on CYP-Mediated Drug Metabolism
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Han, Young Min | - |
dc.contributor.author | Kim, In Sook | - |
dc.contributor.author | Rehman, Shaheed Ur | - |
dc.contributor.author | Choe, Kevin | - |
dc.contributor.author | Yoo, Hye Hyun | - |
dc.date.accessioned | 2021-06-22T22:02:00Z | - |
dc.date.available | 2021-06-22T22:02:00Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2015-07 | - |
dc.identifier.issn | 1741-427X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/21009 | - |
dc.description.abstract | Eurycoma longifolia (Simaroubaceae) is a popular folk medicine that has traditionally been used in Southeast Asia as an antimalarial, aphrodisiac, antidiabetic, and antimicrobial and in antipyretic remedies. This study evaluates the effects of Eurycoma longifolia extract on cytochrome P450 (CYP) enzyme-mediated drug metabolism to predict the potential for herb-drug interactions. Methanolic extract of E. longifolia root was tested at concentrations of 1, 3, 10, 30, 100, 300, and 1000 mu g/mL in human liver microsomes or individual recombinant CYP isozymes. The CYP inhibitory activity was measured using the cocktail probe assay based on liquid chromatography-tandem mass spectrometry. E. longifolia showed weak, concentration-dependent inhibition of CYP1A2, CYP2A6, and CYP2C19. The inhibitory effects on these CYP isozymes were further tested using individual recombinant CYP isozymes, showing IC50 values of 324.9, 797.1, and 562.9 mu g/mL, respectively. In conclusion, E. longifolia slightly inhibited the metabolic activities of CYP1A2, CYP2A6, and CYP2C19 but this issue requires careful attention in taking herbal medicines or dietary supplements containing E. longifolia extracts. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Oxford University Press | - |
dc.title | In Vitro Evaluation of the Effects of Eurycoma longifolia Extract on CYP-Mediated Drug Metabolism | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choe, Kevin | - |
dc.contributor.affiliatedAuthor | Yoo, Hye Hyun | - |
dc.identifier.doi | 10.1155/2015/631329 | - |
dc.identifier.scopusid | 2-s2.0-84937723621 | - |
dc.identifier.wosid | 000358237000001 | - |
dc.identifier.bibliographicCitation | Evidence-based Complementary and Alternative Medicine, v.2015, pp.1 - 7 | - |
dc.relation.isPartOf | Evidence-based Complementary and Alternative Medicine | - |
dc.citation.title | Evidence-based Complementary and Alternative Medicine | - |
dc.citation.volume | 2015 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 7 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Integrative & Complementary Medicine | - |
dc.relation.journalWebOfScienceCategory | Integrative & Complementary Medicine | - |
dc.subject.keywordPlus | HUMAN CYTOCHROME-P450 ENZYMES | - |
dc.subject.keywordPlus | BETA-CARBOLINE ALKALOIDS | - |
dc.subject.keywordPlus | ROOTS | - |
dc.subject.keywordPlus | QUASSINOIDS | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordAuthor | HUMAN CYTOCHROME-P450 ENZYMES | - |
dc.subject.keywordAuthor | BETA-CARBOLINE ALKALOIDS | - |
dc.subject.keywordAuthor | ROOTS | - |
dc.subject.keywordAuthor | CONSTITUENTS | - |
dc.subject.keywordAuthor | QUASSINOIDS | - |
dc.subject.keywordAuthor | INHIBITION | - |
dc.identifier.url | https://www.hindawi.com/journals/ecam/2015/631329/ | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.